Article
Two lawsuits have been filed against Anthem Blue Cross for denying coverage to 2 women for the hepatitis C medication Harvoni.
Two lawsuits have been filed against Anthem Blue Cross for denying coverage to 2 women for the hepatitis C medication Harvoni. Both lawsuits claim the insurer denied coverage for Harvoni, because the amount of liver damage sustained by the women was insufficient to warrant payment for the drug, and the treatment was not medically necessary.
The arguments go back and forth. In its denial letter sent to 1 of the plaintiffs, Anthem said that the women's liver had not yet sustained enough damage. The plaintiff argues that preventing her liver from getting to that stage would be the point of her treatment.
Read the complete report on The Wall Street Journal: http://on.wsj.com/1FUq4Eu